title: Reply to Alexander S. Parker, Brad C. Leibovich, Jeanette E. Eckel-Passow, John C. Cheville's letter to the editor re: Samira A. Brooks, A. Rose Brannon, Joel S. Parker, et al. ClearCode34: a prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol 2014;66:77-84.
authors.affiliation: UNC Lineberger Cancer Center, Chapel Hill, NC, USA; Department of Medicine, Division of Hematology and Oncology, and Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. Electronic address: Rathmell@med.unc.edu.
authors.forename: W Kimryn
authors.initials: WK
authors.lastname: Rathmell
authors.affiliation: UNC Lineberger Cancer Center, Chapel Hill, NC, USA.
authors.forename: Samira A
authors.initials: SA
authors.lastname: Brooks
authors.affiliation: UNC Lineberger Cancer Center, Chapel Hill, NC, USA.
authors.forename: Joel S
authors.initials: JS
authors.lastname: Parker
authors.affiliation: UNC Lineberger Cancer Center, Chapel Hill, NC, USA; Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
authors.forename: Matthew E
authors.initials: ME
authors.lastname: Nielsen
mesh_terms: D000818:Animals; D014408:Biomarkers, Tumor / Q000235:genetics*; D002292:Carcinoma, Renal Cell / Q000235:genetics*; D005260:Female; D015870:Gene Expression; D006801:Humans; D007680:Kidney Neoplasms / Q000235:genetics*; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000235:genetics*
chemical_list: D014408:Biomarkers, Tumor